IMPLANDENT - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 294,756 | 292,408 | 280,300 | 363,366 | 376,442 | 378,483 | 386,481 | 380,091 |
| Profit before tax | 22,589 | 21,337 | 18,515 | 8,752 | 15,789 | 10,088 | 16,384 | 16,746 |
| Net profit | 21,342 | 20,105 | 17,329 | 6,847 | 13,428 | 7,630 | 13,134 | 14,056 |
| Equity | 198,525 | 198,630 | 175,959 | 145,358 | 128,786 | 131,416 | 139,550 | 147,724 |
| Liabilities | 49,679 | 54,958 | 50,868 | 183,890 | 144,720 | 137,708 | 131,970 | 74,928 |
| Non-current assets | 109,546 | 109,949 | 88,287 | 262,002 | 226,991 | 229,585 | 189,772 | 157,115 |
| Current assets | 136,304 | 141,587 | 135,400 | 65,695 | 43,605 | 35,966 | 78,047 | 62,699 |
| Total assets | 245,850 | 251,536 | 223,687 | 327,697 | 270,596 | 265,551 | 267,819 | 219,814 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 33,114 | 35,212 | 35,980 |
| Social insurance contributions | - | - | - | - | - | 38,791 | 41,600 | 43,040 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +5.8% | -0.8% | -4.1% | +29.6% | +3.6% | +0.5% | +2.1% | -1.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.7% | 8.0% | 7.7% | 2.1% | 5.0% | 2.9% | 4.9% | 6.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.8% | 10.1% | 9.8% | 4.7% | 10.4% | 5.8% | 9.4% | 9.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.2% | 6.9% | 6.2% | 1.9% | 3.6% | 2.0% | 3.4% | 3.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.7% | 7.3% | 6.6% | 2.4% | 4.2% | 2.7% | 4.2% | 4.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.3 | 1.3 | 1.1 | 1.0 | 0.9 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 38,446 | 40,332 | 38,223 | 44,953 | 47,055 | 47,808 | 48,310 | 43,856 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
IMPLANDENT - Social security debts
The company had no debts to Sodra
IMPLANDENT - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-16 | 2026-01-30 | 0.88 |
| 2026-01-15 | 2026-01-15 | 883.23 |
| 2026-01-10 | 2026-01-14 | 880.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
IMPLANDENT, UAB (code 122058530) is a Private Limited Liability Company engaged in dental practice care activities. In 2025, revenue reached €380.1K, slightly below €386.5K in 2024 and broadly in line with €378.5K in 2023. Net profit increased to €14.1K in 2025 from €13.1K in 2024 and €7.6K in 2023, while the profit margin improved to 3.7% from 3.4% and 2.0% respectively. Total assets declined to €219.8K in 2025 from €267.8K in 2024, with equity at €147.7K and liabilities at €74.9K. The equity ratio stood at 67.2% and debt-to-equity at 0.51, indicating a solid capital structure. ROE was 9.5%, ROA 6.4%, and asset turnover 1.73x. Revenue per employee was €47.5K, and profit per employee was €1.8K.